Literature DB >> 17563459

Gene-environment interactions in the pathogenesis of type 2 diabetes and metabolism.

Niels Grarup1, Gitte Andersen.   

Abstract

PURPOSE OF REVIEW: Gene-environment interaction can be viewed as a departure from an otherwise expected additivity of genetic and environmental factors on a given outcome measure. Important genetic and environmental factors contribute to the pathogenesis of type 2 diabetes and intermediary traits, probably modulated by their complex interaction. This paper provides an update on the current literature investigating gene-environment interactions of type 2 diabetes and metabolic phenotypes, and discusses the future perspectives of this research. RECENT
FINDINGS: Recent advances in gene-environment interaction studies of metabolism have involved LIPC, APOA5 and PPARG variation, and nutrition and physical activity, of which the most consistently replicated observations have been obtained for APOA5. Also, intervention studies of the promising TCF7L2 type 2 diabetes gene and possible future strategies are discussed.
SUMMARY: Possibly as a result of the complexity of these multifactorial diseases, recent years have seen only limited success in unravelling significant gene-environment interactions, but important insights have been gained and they hold promise for implementation in lifestyle intervention strategies. We need to evolve to more complex, but realistic, scenarios involving several genes and environmental factors. Recent progress in statistical methods allowing for higher-order interactions may make this possible.

Entities:  

Mesh:

Year:  2007        PMID: 17563459     DOI: 10.1097/MCO.0b013e3281e2c9ab

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  25 in total

1.  Etiology of Obesity Over the Life Span: Ecological and Genetic Highlights from Asian Countries.

Authors:  Pei Nee Chong; Christinal Pey Wen Teh; Bee Koon Poh; Mohd Ismail Noor
Journal:  Curr Obes Rep       Date:  2014-03

2.  The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes.

Authors:  T Sparsø; G Andersen; T Nielsen; K S Burgdorf; A P Gjesing; A L Nielsen; A Albrechtsen; S S Rasmussen; T Jørgensen; K Borch-Johnsen; A Sandbaek; T Lauritzen; S Madsbad; T Hansen; O Pedersen
Journal:  Diabetologia       Date:  2007-11-16       Impact factor: 10.122

3.  Detecting gene-environment interactions using a combined case-only and case-control approach.

Authors:  Dalin Li; David V Conti
Journal:  Am J Epidemiol       Date:  2008-12-13       Impact factor: 4.897

4.  Genetics of type 2 diabetes.

Authors:  Omar Ali
Journal:  World J Diabetes       Date:  2013-08-15

5.  Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion.

Authors:  Martin Heni; Caroline Ketterer; Claus Thamer; Silke A Herzberg-Schäfer; Martina Guthoff; Norbert Stefan; Fausto Machicao; Harald Staiger; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Diabetes       Date:  2010-08-29       Impact factor: 9.461

Review 6.  The WNT signalling pathway and diabetes mellitus.

Authors:  T Jin
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

Review 7.  Insulin signaling regulating genes: effect on T2DM and cardiovascular risk.

Authors:  Sabrina Prudente; Eleonora Morini; Vincenzo Trischitta
Journal:  Nat Rev Endocrinol       Date:  2009-12       Impact factor: 43.330

Review 8.  "H" for Heterogeneity in the Algorithm for Type 2 Diabetes Management.

Authors:  Pieralice Silvia; Zampetti Simona; Maddaloni Ernesto; Buzzetti Raffaella
Journal:  Curr Diab Rep       Date:  2020-03-20       Impact factor: 4.810

9.  LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion.

Authors:  Mary F Feitosa; Richard H Myers; James S Pankow; Michael A Province; Ingrid B Borecki
Journal:  Atherosclerosis       Date:  2008-09-17       Impact factor: 5.162

10.  Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes.

Authors:  Xuefeng Li; Yancheng Xu; Yan Ding; Chengming Qin; Zhe Dai; Li Niu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.